Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
Report top-line results during the second half of 2025 from the APEX trial. APEX is a registration-directed, global, open-label trial of bezuclastinib in patients with Advanced Systemic Mastocytosis ...
Hosted on MSN1d
Logos, Emblems and Monograms Photoshop Tutorial Links from Blue Lightning TV
A collection of Photoshop tutorials by Blue Lightning TV, showing how to create powerful logos, emblems and monograms. Note: ...
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
About Cogent Biosciences, Inc. Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, ...